Carina

Ronovo Surgical (Shanghai) developed the Carina, a modular laparoscopic soft-tissue surgical robot for minimally invasive surgery. The Carina received NMPA approval in 2025 and is designed with a modular architecture that allows reconfiguration for different laparoscopic surgical workflows. The system targets hospitals seeking to expand robotic-assisted laparoscopic surgery capacity.

Carina is at the research stage: it exists, but DEPLOY has no verified real-world deployment on record. Manufacturer capability claims should be read as claims pending independent verification.

Carina is made by Ronovo Surgical, based in Shanghai, China, founded in 2019.

Carina is at research stage and is not yet available for sale.

On the DEPLOY registry, comparable surgical robots to Carina include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.

Carina and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. Carina has 0 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Carina ranks in roughly the top 37% of surgical models tracked by the registry.

Carina is at the research stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Research stage means active development without commercial deployments on file.

No verified deployments of Carina are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.

Carina has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.